NABUMETONE Tablets USP — Class III drug recall D-0773-2016
Terminated recall by Teva Pharmaceuticals USA, reported 2016-03-23, distributed nationwide. Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
| Recall number | D-0773-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2015-11-19 |
| Classified | 2016-03-11 |
| Reported by FDA | 2016-03-23 |
| Terminated | 2016-11-15 |
| Distributed | Nationwide (US) |
| Quantity | 576 bottles |
| Reason classes | labeling |
| Lot numbers | 05N533, 11/16 |
Product
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
Reason for recall
Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0773-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.